OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutations, inflammation and phenotype of myeloproliferative neoplasms
Sylvie Hermouet
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15

Showing 15 citing articles:

Suppressed activation of the IRF7 and TLR9 by JAK2V617F gold nanoparticles
Berkay Tokcan, Esra Nur Demirtaş, Selçuk Sözer
Immunogenetics (2025) Vol. 77, Iss. 1
Open Access

DNA Methylation in Ph-Negative Myeloproliferative Neoplasms: Prognostic Role and Therapeutic Implications
Paola Barone, Adele Bottaro, Rossana Leanza, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 227-227
Open Access

Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia
Tobias R. Haage, Emmanouil Charakopoulos, Vikas Bhuria, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2

Interleukin-1β, JAK2V617F mutation and inflammation in MPNs
Sylvie Hermouet, Hans Carl Hasselbalch
Blood Advances (2024) Vol. 8, Iss. 16, pp. 4344-4347
Open Access | Times Cited: 2

Exploring the molecular mechanisms between lymphoma and myelofibrosis
Jun-Nuan Wang
American Journal of Translational Research (2024) Vol. 16, Iss. 3, pp. 730-737
Open Access | Times Cited: 1

Bibliometric analysis of worldwide research on Polycythemia Vera in the 21st century
Zhengjiu Cui, Fei Luo, Yuan Zhang, et al.
Annals of Hematology (2024) Vol. 103, Iss. 10, pp. 3905-3920
Closed Access | Times Cited: 1

Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP
Lasse Kjær, Vibe Skov, Morten Kranker Larsen, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 6, pp. 665-668
Open Access | Times Cited: 1

Acute myocardial infarction in myeloproliferative neoplasms
Muhammad Romail Manan, Vincent Kipkorir, Iqra Nawaz, et al.
World Journal of Cardiology (2023) Vol. 15, Iss. 11, pp. 571-581
Open Access | Times Cited: 4

Spatial-transcriptomic profiling: a new lens for understanding myelofibrosis pathophysiology
Edoardo Peroni, Elisabetta Calistri, Rosario Amato, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access

Thromboinflammation in ischemic cerebrovascular patients with the JAK2V617F mutation
Marie Hvelplund Kristiansen, Morten Kranker Larsen, Laura Massarenti, et al.
Thrombosis Research (2024) Vol. 245, pp. 109236-109236
Closed Access

Potential application of bulk RNA sequence in MPNs clinic routine
Shenglong Li, Sanyun Wu, Mingli Xu, et al.
Research Square (Research Square) (2024)
Open Access

HMGB1 as a Biomarker for Myeloproliferative Neoplasm Complicated with Atherosclerosis
Lunbi Wu, Dongxue Han, Xiaodong Zhang, et al.
Research Square (Research Square) (2024)
Open Access

The CHIP-clinic as the catalyst of preventive medicine
Hans Carl Hasselbalch, Vibe Skov, Lasse Kjær, et al.
Frontiers in Hematology (2024) Vol. 3
Open Access

Molecular pathogenesis of myeloproliferative neoplasms: Where do we stand in 2023?
Violaine Havelange, Stefan N. Constantinescu
American Journal of Hematology (2023) Vol. 98, Iss. 10, pp. 1512-1516
Open Access | Times Cited: 1

Multiparametric MRI detects multi-organ impairment in patients with chronic myeloid neoplasms with normal serum biomarkers
Sophie Reed, Charlie Diamond, Samiya Mahmood, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top